Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing–remitting multiple sclerosis: an observational study

OBJECTIVE: To compare outcomes after treatment with autologous haematopoietic stem cell transplantation (AHSCT) and alemtuzumab (ALZ) in patients with relapsing–remitting multiple sclerosis. METHODS: Patients treated with AHSCT (n=69) received a conditioning regimen of cyclophosphamide (200 mg/kg) a...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Neurol Neurosurg Psychiatry
Главные авторы: Zhukovsky, Christina, Sandgren, Sofia, Silfverberg, Thomas, Einarsdottir, Sigrun, Tolf, Andreas, Landtblom, Anne-Marie, Novakova, Lenka, Axelsson, Markus, Malmestrom, Clas, Cherif, Honar, Carlson, Kristina, Lycke, Jan, Burman, Joachim
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2021
Предметы:
Multiple Sclerosis
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7841472/
https://ncbi.nlm.nih.gov/pubmed/33106366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2020-323992
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы